Finance

Beta
Lists
VTGN:BMV
Vistagen Therapeutics Inc
MX$10.65
+9.68%
(+0.94) 1D
Apr 21, 1:54:16 PM GMT-6  ·   MXN
All symbols
SymbolPriceChange% Change
Generating top insights for VTGN...
Mkt. cap
21.39M
Avg. vol.
0.00
Volume
0.00
52-wk high
MX$11.58
52-wk low
MX$9.51
No. of employees
59
Mkt. cap
21.39M
Avg. vol.
0.00
Volume
0.00
52-wk high
MX$11.58
52-wk low
MX$9.51
No. of employees
59
News stories
From sources across the web
About Vistagen Therapeutics Inc
CEO-
Employees59
Founded1998
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websitevistagen.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-15.00K
244.00K
258.00K
303.00K
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
10.21M
11.68M
15.92M
14.22M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.27M
4.37M
4.40M
5.63M
Operating expense
14.48M
16.05M
20.31M
19.85M
Total operating expenses
14.48M
16.05M
20.31M
19.85M
Operating income
-14.50M
-15.80M
-20.05M
-19.55M
Other non operating income
5.00K
-2.00K
6.00K
-
EBT including unusual items
-13.64M
-15.10M
-19.42M
-18.90M
EBT excluding unusual items
-13.64M
-15.10M
-19.42M
-18.90M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-13.64M
-15.10M
-19.42M
-18.90M
Net profit margin
90,900.00%
-6,186.48%
-7,525.97%
-6,237.29%
Earnings per share
-0.44
-0.47
-0.54
-0.45
Interest and investment income
855.00K
711.00K
630.00K
647.00K
Interest expense
-
-
-
-
Net interest expenses
855.00K
711.00K
630.00K
647.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-14.46M
-15.76M
-20.00M
-19.49M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer